Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.
about
Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis AmesImmunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthraxApproaches to modelling the human immune response in transition of candidates from research to development.DNA vaccines for biodefense.A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection.Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.A novel immunogenic spore coat-associated protein in Bacillus anthracis: characterization via proteomics approaches and a vector-based vaccine system.Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge modelSequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodiesThe major neutralizing antibody responses to recombinant anthrax lethal and edema factors are directed to non-cross-reactive epitopes.The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax.Serodiagnosis of human cutaneous anthrax in India using an indirect anti-lethal factor IgG enzyme-linked immunosorbent assay.Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus).
P2860
Q28392659-FB77639A-9535-4F48-9026-956247BDFD0BQ33334776-E588BA52-C9B4-42B5-80E6-30B5520F6620Q33396429-AB91DC6F-3760-48C9-B8FE-D1A51CE365B0Q33661296-5C413D27-4750-4443-A8F1-F083D33A8644Q34614260-F00482AA-8EB9-47B4-BF06-ABF88F01CE3FQ34700706-97356763-E2D0-472F-A4FE-FA3D060BBAD8Q35403794-DF5B3A7C-E4A7-43A3-A1A7-CA0021AAE4AAQ35869311-23BC6E70-3383-4D99-8457-99D7A1787844Q36328022-6F455252-7F4B-4803-BF3E-68C78C3081FFQ36523135-FBB06B32-C122-41D4-98A3-CBF6E4C3E590Q37033014-6A071F98-B423-4FF1-A40B-D2A33EBA2E98Q37033046-867C81C0-2C99-4DCB-91F6-CD98AE24E9A8Q37410339-92BE84BD-FA03-4AC1-BDC9-97E1EB01386FQ39205816-A8DA56A8-46E9-4715-9ACD-B96B461A1121Q41997806-2EDE1A9C-A896-4C39-A4A6-96AB0F4254D7Q44892507-62ABB284-EC52-4B0E-8D99-F3E45858B0C1
P2860
Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Mouse model characterisation f ...... and one outbred mouse strain.
@ast
Mouse model characterisation f ...... and one outbred mouse strain.
@en
type
label
Mouse model characterisation f ...... and one outbred mouse strain.
@ast
Mouse model characterisation f ...... and one outbred mouse strain.
@en
prefLabel
Mouse model characterisation f ...... and one outbred mouse strain.
@ast
Mouse model characterisation f ...... and one outbred mouse strain.
@en
P2093
P1476
Mouse model characterisation f ...... and one outbred mouse strain.
@en
P2093
Flick-Smith HC
Williamson ED
P356
10.1016/J.MICPATH.2004.10.007
P577
2004-12-19T00:00:00Z